Bavanthi Balakrishnar

699 total citations
25 papers, 469 citations indexed

About

Bavanthi Balakrishnar is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Bavanthi Balakrishnar has authored 25 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Pulmonary and Respiratory Medicine and 6 papers in Surgery. Recurrent topics in Bavanthi Balakrishnar's work include Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (5 papers) and Testicular diseases and treatments (4 papers). Bavanthi Balakrishnar is often cited by papers focused on Prostate Cancer Treatment and Research (7 papers), Estrogen and related hormone effects (5 papers) and Testicular diseases and treatments (4 papers). Bavanthi Balakrishnar collaborates with scholars based in Australia, Netherlands and Switzerland. Bavanthi Balakrishnar's co-authors include Howard Gurney, Mark Wong, Bo Gao, Arthur Clements, Paul de Souza, Therese M. Becker, Wei Chua, Yafeng Ma, Francis Young and Christopher Liddle and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Bavanthi Balakrishnar

24 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bavanthi Balakrishnar Australia 10 195 186 160 114 77 25 469
Alissa K. Robbins United States 12 239 1.2× 261 1.4× 286 1.8× 100 0.9× 80 1.0× 19 919
Youwei Bi United States 14 275 1.4× 307 1.7× 225 1.4× 89 0.8× 27 0.4× 25 768
Annemieke J.M. Nieuweboer Netherlands 14 288 1.5× 327 1.8× 180 1.1× 171 1.5× 36 0.5× 19 738
Woo Sun Kwon South Korea 16 401 2.1× 271 1.5× 267 1.7× 128 1.1× 25 0.3× 51 677
Jeanne Fourie Zirkelbach United States 11 267 1.4× 218 1.2× 122 0.8× 104 0.9× 33 0.4× 14 557
Celine Pitou United States 14 289 1.5× 56 0.3× 347 2.2× 73 0.6× 24 0.3× 24 641
Olga Ujhelly Hungary 10 514 2.6× 110 0.6× 400 2.5× 31 0.3× 73 0.9× 15 759
Rosario Garrido United States 9 235 1.2× 222 1.2× 335 2.1× 71 0.6× 13 0.2× 11 651
Leslie Rodgers Laufman United States 8 621 3.2× 114 0.6× 309 1.9× 197 1.7× 127 1.6× 11 860
Ruifang Xu China 12 58 0.3× 72 0.4× 198 1.2× 60 0.5× 53 0.7× 27 523

Countries citing papers authored by Bavanthi Balakrishnar

Since Specialization
Citations

This map shows the geographic impact of Bavanthi Balakrishnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bavanthi Balakrishnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bavanthi Balakrishnar more than expected).

Fields of papers citing papers by Bavanthi Balakrishnar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bavanthi Balakrishnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bavanthi Balakrishnar. The network helps show where Bavanthi Balakrishnar may publish in the future.

Co-authorship network of co-authors of Bavanthi Balakrishnar

This figure shows the co-authorship network connecting the top 25 collaborators of Bavanthi Balakrishnar. A scholar is included among the top collaborators of Bavanthi Balakrishnar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bavanthi Balakrishnar. Bavanthi Balakrishnar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liang, Roger J., Diana Adams, Felicia Roncolato, et al.. (2024). Adherence Outcomes and Risk Factors Predicting Nonadherence to Active Surveillance in Patients With Stage 1 Testicular Germ Cell Tumors. Clinical Genitourinary Cancer. 22(4). 102116–102116. 1 indexed citations
2.
3.
Hong, Jun Hee, et al.. (2022). A Rare Case of Castrate-Resistant Prostate Adenocarcinoma with a Unilateral Testicular Metastasis Mimicking a Primary Testicular Tumour. SHILAP Revista de lepidopterología. 15(3). 1055–1062. 2 indexed citations
4.
Lock, John G., Yafeng Ma, David G. Harman, et al.. (2022). Choice of antibody is critical for specific and sensitive detection of androgen receptor splice variant-7 in circulating tumor cells. Scientific Reports. 12(1). 16159–16159. 2 indexed citations
5.
Hong, Jun Hee, et al.. (2022). Review of Toxicities of PARP Inhibitors in Metastatic Castrate Resistant Prostate Cancer. Clinical Genitourinary Cancer. 21(1). 183–193. 9 indexed citations
6.
Young, Francis, Therese M. Becker, Wei Chua, et al.. (2022). Biomarkers of Castrate Resistance in Prostate Cancer: Androgen Receptor Amplification and T877A Mutation Detection by Multiplex Droplet Digital PCR. Journal of Clinical Medicine. 11(1). 257–257. 8 indexed citations
7.
Balakrishnar, Bavanthi, Megan Crumbaker, Sandra Turner, et al.. (2021). Patterns of care and outcomes of men with germ cell tumors in a high‐volume Australian center. Asia-Pacific Journal of Clinical Oncology. 18(2). e23–e31. 1 indexed citations
8.
Po, Joseph W., Yafeng Ma, Alison W. S. Luk, et al.. (2021). Single-Cell Analysis of BRAFV600E and NRASQ61R Mutation Status in Melanoma Cell Lines as Method Generation for Circulating Melanoma Cells. Methods in molecular biology. 2265. 277–286.
9.
Po, Joseph W., Yafeng Ma, Bavanthi Balakrishnar, et al.. (2021). PD-L1 Detection on Circulating Melanoma Cells. Methods in molecular biology. 2265. 223–233. 1 indexed citations
10.
Low, Siew‐Kee, Peter Fox, Bavanthi Balakrishnar, et al.. (2020). Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratio. The Breast. 54. 229–234. 4 indexed citations
11.
Balakrishnar, Bavanthi, et al.. (2019). Patterns of immunotherapy use and management of toxicities in regional and tertiary settings. Internal Medicine Journal. 49(8). 1010–1015. 1 indexed citations
12.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2019). Tamoxifen-induced severe hot flashes and endoxifen levels: is dose reduction a safe and effective strategy?. The Breast. 46. 52–57. 9 indexed citations
13.
14.
Balakrishnar, Bavanthi, Wei Chua, Joseph Descallar, et al.. (2019). Patterns of Presentation and Treatment Outcomes of Non–clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia. Clinical Genitourinary Cancer. 17(3). e565–e569. 1 indexed citations
15.
Sabanathan, Dhanusha, Alison Y. Zhang, Peter Fox, et al.. (2017). Dose individualization of sunitinib in metastatic renal cell cancer: toxicity-adjusted dose or therapeutic drug monitoring. Cancer Chemotherapy and Pharmacology. 80(2). 385–393. 22 indexed citations
16.
Fox, Peter, Rosemary L. Balleine, Bo Gao, et al.. (2016). Dose Escalation of Tamoxifen in Patients with Low Endoxifen Level: Evidence for Therapeutic Drug Monitoring—The TADE Study. Clinical Cancer Research. 22(13). 3164–3171. 64 indexed citations
17.
Fox, Peter, Bavanthi Balakrishnar, Rosemary L. Balleine, et al.. (2016). Simplified CYP2D6 metabolizer phenotype categorization of patients treated with tamoxifen: Role for endoxifen level monitoring?. Journal of Clinical Oncology. 34(15_suppl). 536–536. 1 indexed citations
18.
Leeuwen, Marina T. van, Howard Gurney, Jennifer Turner, et al.. (2016). Patterns and trends in the incidence of paediatric and adult germ cell tumours in Australia, 1982–2011. Cancer Epidemiology. 43. 15–21. 9 indexed citations
19.
Kloth, Jacqueline S. L., Heinz‐Josef Klümpen, Huixin Yu, et al.. (2013). Predictive Value of CYP3A and ABCB1 Phenotyping Probes for the Pharmacokinetics of Sunitinib: the ClearSun Study. Clinical Pharmacokinetics. 53(3). 261–269. 22 indexed citations
20.
Fox, Peter, Bo Gao, Bavanthi Balakrishnar, et al.. (2013). Factors predicting endoxifen levels in breast cancer patients taking standard-dose tamoxifen and following dose escalation.. Journal of Clinical Oncology. 31(15_suppl). 543–543. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alissa K. Robbins Breakdown of academic impact, for papers by Youwei Bi Breakdown of academic impact, for papers by Annemieke J.M. Nieuweboer Breakdown of academic impact, for papers by Woo Sun Kwon Breakdown of academic impact, for papers by Jeanne Fourie Zirkelbach Breakdown of academic impact, for papers by Celine Pitou Breakdown of academic impact, for papers by Olga Ujhelly Breakdown of academic impact, for papers by Rosario Garrido Breakdown of academic impact, for papers by Leslie Rodgers Laufman Breakdown of academic impact, for papers by Ruifang Xu
Rankless by CCL
2026